Blueprint Medicines Corp (BPMC)
107.76
+1.06
(+0.99%)
USD |
NASDAQ |
May 13, 09:55
Blueprint Medicines Price: 107.76 for May 13, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 10, 2024 | 108.71 | 109.02 | 106.01 | 106.70 | 406715.0 |
May 09, 2024 | 109.00 | 109.87 | 108.00 | 108.34 | 553293.0 |
May 08, 2024 | 107.50 | 109.14 | 106.48 | 108.78 | 478493.0 |
May 07, 2024 | 105.99 | 109.41 | 103.31 | 108.55 | 755189.0 |
May 06, 2024 | 107.93 | 108.50 | 105.48 | 106.25 | 803183.0 |
May 03, 2024 | 109.82 | 110.93 | 106.07 | 107.19 | 1.004M |
May 02, 2024 | 103.88 | 110.16 | 100.90 | 107.00 | 2.004M |
May 01, 2024 | 91.44 | 96.40 | 90.85 | 94.86 | 883687.0 |
Apr 30, 2024 | 91.45 | 93.37 | 90.74 | 91.34 | 529234.0 |
Apr 29, 2024 | 93.52 | 94.91 | 91.12 | 93.10 | 622933.0 |
Apr 26, 2024 | 92.76 | 94.98 | 90.47 | 93.00 | 725963.0 |
Apr 25, 2024 | 89.54 | 91.46 | 88.46 | 90.73 | 755177.0 |
Apr 24, 2024 | 91.78 | 93.74 | 90.43 | 92.26 | 588540.0 |
Apr 23, 2024 | 90.48 | 94.67 | 89.19 | 92.29 | 788709.0 |
Apr 22, 2024 | 87.76 | 92.66 | 86.52 | 90.61 | 792073.0 |
Apr 19, 2024 | 88.45 | 89.90 | 84.62 | 86.85 | 813144.0 |
Apr 18, 2024 | 87.93 | 91.76 | 86.56 | 88.90 | 734936.0 |
Apr 17, 2024 | 87.31 | 89.69 | 86.76 | 88.38 | 728290.0 |
Apr 16, 2024 | 84.51 | 88.08 | 84.44 | 86.09 | 410709.0 |
Apr 15, 2024 | 87.18 | 87.84 | 84.33 | 85.18 | 506386.0 |
Apr 12, 2024 | 92.59 | 93.00 | 87.03 | 87.25 | 484715.0 |
Apr 11, 2024 | 91.47 | 92.56 | 90.44 | 92.25 | 404526.0 |
Apr 10, 2024 | 88.13 | 90.59 | 84.55 | 90.49 | 569839.0 |
Apr 09, 2024 | 92.27 | 93.93 | 91.34 | 92.20 | 710621.0 |
Apr 08, 2024 | 92.33 | 93.21 | 90.56 | 91.54 | 435421.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
37.97
Minimum
Feb 24 2023
124.48
Maximum
Dec 23 2020
75.14
Average
74.89
Median
Price Benchmarks
Ligand Pharmaceuticals Inc | 87.40 |
Apellis Pharmaceuticals Inc | 42.62 |
Alnylam Pharmaceuticals Inc | 151.61 |
Biomarin Pharmaceutical Inc | 81.03 |
Corcept Therapeutics Inc | 27.95 |
Price Related Metrics
PS Ratio | 23.47 |
Price to Book Value | 21.72 |
Earnings Yield | -4.46% |
Market Cap | 6.748B |